# Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

> **NCT00000517** · PHASE3 · COMPLETED · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Arrhythmia
- Atrial Fibrillation
- Cardiovascular Diseases
- Cerebral Embolism and Thrombosis
- Cerebrovascular Disorders
- Heart Diseases
- Thrombophlebitis
- Cerebrovascular Accident

## Interventions

- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT00000517
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1985-07
- **Primary completion:** 1991-06
- **Final completion:** 1991-06
- **Target enrollment:** — (—)
- **Last updated:** 2014-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000517, "Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00000517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*